Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DLO +19.6%, TARS +11.6%, NN +8.4%, DIS +8%, SONO +6.7%, TLN +5.6%, BZH +5.1%, NTES +3.4%, ASML +3.3% (long-term outlook), DGII +2.8%, CAPR +2.3%, NOMD +1.5%, KLIC +1.2% (also announces new $300 mln share repurchase program, raises dividend), KYTX +1%, SBH +1%
Other news:
- ZETA +11.5% (Responds to Short-Seller Report; authorizes $100 million stock repurchase program)
- TIL +9% (files $200 mln mixed shelf securities offering)
- TPR +5.9% (Capri Holdings (CPRI) announces termination of merger with TPR)
- ACIU +5.8% (reports positive interim results from phase 2 trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease)
- CNH +5.2% (David Einhorn builds new position, calls shares cheap, according to CNBC)
- PTCT +3.3% (receives FDA approval for AADC Deficiency Gene Therapy)
- BOOM +2.3% (CEO to retire)
- KSCP +2.3% (VZ announces partnership with KSCP)
- MKL +2.2% (authorizes new $2 bln share repurchase program)
- ALLO +1.8% (to discontinue enrollment in Phase 1 cohort in the ALPHA2 trial)
- CBUS +1.8% (Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola)
- SEZL +1.3% (files mixed shelf securities offering)
- XRAY +1.3% (CEO bought 11,306 shares)
- RILY +1% (to delay 10-Q filing)
- DHI +1% (Soros Capital new position)
Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- IBTA -19.3%, HROW -18.9%, TSHA -14.5%, ZK -10.4%, AFYA -8.7%, NU -6.5%, AAP -6.2%, JJSF -6%, TTEK -5.5%, BILI -4.8%, BV -3.7%, NICE -3.7%, HP -3.3%, DADA -3.2%, CSCO -3%, DDD -1.7% (guides Q3 revs below consensus; also to delay 10-Q filing), JD -1%